Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
RMD [NYSE]
ResMed Inc.
Index- P/E26.60 EPS (ttm)2.47 Insider Own0.90% Shs Outstand140.56M Perf Week-8.60%
Market Cap9.23B Forward P/E22.74 EPS next Y2.89 Insider Trans-34.64% Shs Float139.72M Perf Month-6.65%
Income352.10M PEG2.13 EPS next Q0.65 Inst Own54.10% Short Float11.62% Perf Quarter1.15%
Sales1.62B P/S5.71 EPS this Y13.80% Inst Trans-0.02% Short Ratio18.59 Perf Half Y39.68%
Book/sh11.34 P/B5.79 EPS next Y10.99% ROA15.00% Target Price64.57 Perf Year41.41%
Cash/sh6.27 P/C10.49 EPS next 5Y12.47% ROE21.10% 52W Range45.29 - 75.33 Perf YTD17.72%
Dividend1.12 P/FCF52.92 EPS past 5Y20.30% ROI15.50% 52W High-12.78% Beta0.69
Dividend %1.70% Quick Ratio5.20 Sales past 5Y11.10% Gross Margin62.70% 52W Low45.05% ATR1.76
Employees4100 Current Ratio6.00 Sales Q/Q10.10% Oper. Margin25.60% RSI (14)31.16 Volatility2.09% 1.84%
OptionableYes Debt/Eq0.28 EPS Q/Q6.70% Profit Margin21.80% Rel Volume3.58 Prev Close73.38
ShortableYes LT Debt/Eq0.28 EarningsApr 23 AMC Payout42.40% Avg Volume873.57K Price65.70
Recom2.40 SMA20-9.72% SMA50-5.49% SMA20015.09% Volume3,123,073 Change-10.47%
Apr-24-15Downgrade Macquarie Outperform → Neutral
Jan-27-15Reiterated Northland Capital Under Perform $40 → $44
Jan-23-15Upgrade Needham Hold → Buy
Jan-23-15Reiterated Canaccord Genuity Hold $42 → $50
May-27-14Downgrade Northland Capital Market Perform → Under Perform
Jan-24-14Reiterated Canaccord Genuity Hold $49 → $43
Oct-08-13Initiated Northland Capital Market Perform $44
Jul-16-13Initiated Needham Hold
Mar-07-13Reiterated Mizuho Neutral $45 → $42
Jan-25-13Reiterated Mizuho Neutral $41 → $45
Oct-26-12Reiterated Mizuho Neutral $39 → $41
Oct-22-12Reiterated Mizuho Neutral $33 → $39
Aug-06-12Reiterated Feltl & Co. Hold $35.75 → $40
Jul-19-12Downgrade Feltl & Co. Buy → Hold $38 → $35.75
Apr-27-12Upgrade Feltl & Co. Hold → Buy $38
Apr-27-12Reiterated Mizuho Neutral $28 → $32
Mar-28-12Downgrade Feltl & Co. Buy → Hold
Jan-17-12Downgrade Feltl & Co. Strong Buy → Buy $35 → $33.15
Dec-20-11Upgrade Feltl & Co. Buy → Strong Buy $39.10 → $35
Oct-25-11Downgrade Feltl & Co. Strong Buy → Buy $40.40 → $39.10
Apr-24-15 10:48AM  ResMed downgraded by Macquarie -10.47%
09:56AM  ResMed Beats Q3 Earnings by a Penny, Misses on Revenues - Analyst Blog
Apr-23-15 06:10PM  ResMed beats 3Q profit forecasts
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today
04:29PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 at noodls
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q3 2015 ResMed Inc Earnings Release - After Market Close
Apr-21-15 01:40PM  ResMed (RMD) Poised to Outshine Q3 Earnings Estimates - Analyst Blog Zacks
Apr-02-15 04:41PM  ResMed To Announce Third Quarter 2015 Results Other
04:30PM  ResMed To Announce Third Quarter 2015 Results PR Newswire
Mar-12-15 09:32AM  ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting at noodls
09:00AM  ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting PR Newswire
Mar-10-15 02:00PM  ResMed Makes It Big on Women's Day, Unveils SDB Device - Analyst Blog
Mar-06-15 06:27AM  ResMed Launches AirSense 10 AutoSet for Her: A Complete Integrated Sleep Solution for Europe's 1 in 5 Women Living with Sleep Apnoea PR Newswire
Feb-24-15 04:49PM  ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog
Feb-16-15 09:17PM  Australian shares slip as Greek worries weigh
Feb-12-15 06:03PM  ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action Other
05:30PM  ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action PR Newswire
Feb-11-15 04:09PM  ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Feb-10-15 08:30AM  ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers PR Newswire
Feb-05-15 01:04PM  RESMED INC Financials EDGAR Online Financials
Feb-02-15 08:30AM  Easy-to-Use AirView Patient Management System by ResMed Now Integrates Directly with Brightree PR Newswire
Feb-01-15 07:07PM  10-Q for ResMed, Inc. Company Spotlight
Jan-30-15 06:02AM  RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Jan-26-15 09:00AM  ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog Zacks
Jan-23-15 12:49PM  ResMed Stock Hits High As Growth Reignites at Investor's Business Daily +5.46%
11:18AM  ResMed (RMD) Stock Continues to Rise Today on Strong Quarterly Results at TheStreet
Jan-22-15 04:43PM  ResMed beats Street 2Q forecasts AP
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online
04:05PM  ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q2 2015 ResMed Inc Earnings Release - After Market Close CCBN
Jan-20-15 12:20PM  Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog Zacks
Dec-23-14 06:24PM  ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical PR Newswire
Dec-18-14 04:30PM  ResMed To Announce Second Quarter 2015 Results PR Newswire
Dec-12-14 08:00AM  Zimmer Holdings Names Michael Farrell to Board of Directors PR Newswire
Dec-04-14 08:00AM  ResMed Unveils AirCurve 10 Series - Bringing More Therapy Choices to the ResMed Air Solutions Series PR Newswire
Nov-25-14 02:36PM  RESMED INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Nov-19-14 02:00PM  ResMed Strong on Q1 Results, Huge OSA Market Potential Zacks
Nov-18-14 08:00AM  ResMed's New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit PR Newswire
Nov-03-14 07:08PM  10-Q for ResMed, Inc. Company Spotlight
Oct-31-14 06:08AM  RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-30-14 10:50AM  [$$] Nintendo Introducing Device to Improve Sleep at The Wall Street Journal
Oct-29-14 11:05PM  Nintendo to develop "quality of life" device to track sleep, fatigue - CEO Reuters
Oct-27-14 08:50AM  ResMed Posts In-Line Earnings on Revenue Beat in Q1 Zacks
06:37AM  Strength Seen in ResMed (RMD): Stock Gains 9.1% Zacks
Oct-24-14 03:00AM  Asia stocks mixed as Ebola, China concerns offset US gains at CNBC +9.06%
Oct-23-14 06:21PM  ResMed meets 1Q profit forecasts AP
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online
04:05PM  RESMED Inc. Announces Results for the First Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q1 2015 ResMed Inc Earnings Release - After Market Close CCBN
Oct-21-14 08:30AM  ResMed myAir Patient Engagement Platform Supports and Coaches Patients to Improve Compliance PR Newswire
08:00AM  ResMed Enhances U-Sleep Patient Management Platform With Action View For Easier Management By Exception PR Newswire
Oct-20-14 08:00AM  ResMed Launches ResMed Data Exchange PR Newswire
Oct-10-14 02:20PM  Resmed Drops despite Launch of S+ Sleep Solution App Zacks
Oct-07-14 04:24PM  [video] The Best Sleep Tracking Gadgets at MarketWatch
08:00AM  ResMed Launches S+, the World's First Non-Contact System That Helps Consumers Measure, Analyze and Improve Their Sleep PR Newswire
Oct-02-14 04:30PM  ResMed To Announce First Quarter 2015 Results PR Newswire
Oct-01-14 08:00AM  ResMed Launches Initiative to Help Women Get Better Sleep PR Newswire
Sep-29-14 03:04PM  ResMed and Brightree Strengthen Integrated Sleep Compliance Management Capabilities PR Newswire
Sep-17-14 05:25PM  Resmed-FairView Sleep Apnea Data Sharing Drags Shares Zacks
Sep-15-14 08:00AM  ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System PR Newswire
Sep-10-14 11:15AM  Insider Trading Alert - IRM, RMD And AMTD Traded By Insiders at TheStreet
Sep-04-14 09:00PM  APEX and ResMed Resolve Patent Disputes PR Newswire
01:50PM  Resmed (RMD) Shares Up on Favorable Sleep Apnea Study Zacks
Sep-02-14 10:42AM  Stock Picks For An Emerging Markets Selloff at Barrons.com
08:00AM  ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. PR Newswire
Aug-31-14 08:00AM  ESC Congress 2014 Highlights: Heart Failure Patients with Sleep-Disordered Breathing More Accurately Diagnosed Through At-Home, Contactless SleepMinderTM Device Than Single Hospital-Based Assessment Business Wire
05:00AM  ESC Congress 2014 highlights: Treating cardiac patients who have sleep apnoea with positive airway pressure (PAP) therapy shown to reduce mortality up to 38% Business Wire
Aug-25-14 03:45PM  ResMed Continues to Disappoint despite OSA Market Potential Zacks
Aug-24-14 01:00PM  ResMed Wins Initial Decision in ITC Patent Infringement Action PR Newswire
Aug-19-14 05:20PM  ResMed Introduces AirSense 10 Devices to Treat Sleep Apnea Zacks
Aug-18-14 08:00AM  ResMed's New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving Efficiency for Healthcare Providers PR Newswire
Aug-12-14 05:30PM  ResMed (RMD) Launches Air Solutions for Improved SDB Therapy Zacks
07:30AM  Qualcomm announces new connected health collaborations at Connect 2014 PR Newswire
Aug-11-14 05:00AM  A New Beginning: ResMed's New Air Solutions Connected Care Platform for Treating Sleep-Disordered Breathing PR Newswire
05:00AM  A New Beginning: ResMed's New Air Solutions Connected Care Platform for Treating Sleep-Disordered Breathing CNW Group
Aug-08-14 08:22AM  RESMED INC Files SEC form 10-K, Annual Report EDGAR Online
Aug-06-14 06:00AM  The R&D elite: America's most innovative companies at CNBC
Aug-04-14 12:20PM  ResMed Misses on Q4 Earnings and Revenues, Hikes Dividend Zacks
08:00AM  Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients PR Newswire
Aug-01-14 12:13PM  Wall Street Transcript Interview with Bob McNamara, the Executive Vice President and CFO of LDR Holding Corporation (LDRH) Wall Street Transcript
Jul-31-14 04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online
04:05PM  RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 PR Newswire
07:07AM  Q4 2014 ResMed Inc. Earnings Release - After Market Close CCBN
Jul-28-14 08:00AM  ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe PR Newswire
Jul-21-14 08:00AM  ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents PR Newswire
Jul-17-14 11:24PM  ANZ, ResMed Inc and Macquarie Group Ltd: Should you buy? Other
Jul-11-14 06:45AM  Call buyers look for rally in ResMed optionMONSTER
Jul-10-14 04:30PM  ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results PR Newswire
Jul-03-14 10:42AM  Why ResMed Inc. Shares Slipped Today at Motley Fool
08:51AM  Morning Movers: Stocks Edge Up on Strong Payrolls; Lululemon Gains on Buyout Speculation at Barrons.com
Jul-02-14 09:44AM  The North American Respiratory Disposables and Anesthesia Disposables Market - Including Masks, Circuits, Nasal Cannulae, Resuscitators, Humidifier Chambers and HMEs, is Poised to Grow 7.5% Annually Through 2019 PR Newswire
Jun-30-14 11:41AM  Why ResMed (RMD) Stock Is Falling Today at TheStreet
09:18AM  On The Fly: Pre-market Movers at theflyonthewall.com
08:00AM  The American Sleep Apnea Association Receives Unprecedented ResMed Donation That Will Save Lives PR Newswire
Jun-29-14 10:18AM  ResMed shares could fall at least 15%, Barron's says theflyonthewall.com
ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. Its products portfolio includes airflow generators, diagnostic products, mask systems, motors, and headgear, as well as other accessories, such as cold passover humidifiers, carry bags, and breathing circuits; and humidifiers comprising H5i and H4i, which connect with the continuous and variable positive airway pressure, and AutoSet flow generators to humidify and heat the air delivered to the patient to prevent the drying of nasal passages. The company also offers data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. It has a collaboration agreement with Qualcomm Life, Inc. to develop connected health solutions based on 2net and HealthyCircles platforms. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farrell Michael J.Chief Executive OfficerApr 15Option Exercise15.525,97592,732128,331Apr 17 12:08 PM
Farrell Michael J.Chief Executive OfficerApr 15Sale73.245,975437,609122,356Apr 17 12:08 PM
PENDARVIS DAVIDChief Administrative OfficerApr 06Option Exercise25.545,500140,47075,591Apr 08 06:19 PM
Reiser AnnePresident - ResMed EuropeApr 06Option Exercise17.303,00051,90071,120Apr 08 06:20 PM
PENDARVIS DAVIDChief Administrative OfficerApr 06Sale72.605,500399,30070,091Apr 08 06:19 PM
Reiser AnnePresident - ResMed EuropeApr 06Sale73.953,000221,85068,120Apr 08 06:20 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Apr 01Option Exercise19.255,833112,28563,503Apr 03 06:57 PM
FARRELL PETER CChairman of the BoardApr 01Option Exercise17.9238,000680,932391,042Apr 03 07:01 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Apr 01Sale70.676,333447,55657,620Apr 03 06:57 PM
FARRELL PETER CChairman of the BoardApr 01Sale70.7036,0002,545,049368,599Apr 03 07:01 PM
Reiser AnnePresident - ResMed EuropeMar 18Option Exercise17.304,00069,20072,120Mar 20 08:12 PM
Reiser AnnePresident - ResMed EuropeMar 18Sale71.454,000285,80068,120Mar 20 08:12 PM
Reiser AnnePresident - ResMed EuropeMar 16Option Exercise17.304,00069,20072,120Mar 18 08:09 PM
Farrell Michael J.Chief Executive OfficerMar 16Option Exercise15.835,97594,579128,031Mar 18 08:10 PM
Reiser AnnePresident - ResMed EuropeMar 16Sale69.104,000276,40068,120Mar 18 08:09 PM
Farrell Michael J.Chief Executive OfficerMar 16Sale69.105,975412,873122,356Mar 18 08:10 PM
Reiser AnnePresident - ResMed EuropeMar 09Option Exercise17.303,00051,90065,198Mar 11 02:26 PM
Reiser AnnePresident - ResMed EuropeMar 09Sale66.753,000200,25062,198Mar 11 02:26 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise25.545,500140,47075,591Mar 05 08:06 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale64.385,500354,06870,091Mar 05 08:06 PM
FARRELL PETER CChairman of the BoardMar 02Option Exercise15.5236,000558,720203,864Mar 04 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Mar 02Option Exercise64.385,833375,54058,120Mar 04 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Mar 02Sale64.396,333407,75058,120Mar 04 08:25 PM
FARRELL PETER CChairman of the BoardMar 02Sale64.6436,0002,326,860167,864Mar 04 08:25 PM
ROBERTS CHRISTOPHER GDirectorFeb 20Sale65.6810,000656,769259,400Feb 24 08:49 PM
Reiser AnnePresident - ResMed EuropeFeb 17Option Exercise17.305,00086,50067,198Feb 19 12:10 PM
Reiser AnnePresident - ResMed EuropeFeb 17Sale66.115,000330,52562,198Feb 19 12:10 PM
Sandercock BrettChief Financial OfficerFeb 13Option Exercise15.52100,0001,552,000160,913Feb 17 07:54 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 05Sale62.355,500342,92570,091Feb 05 06:41 PM
WAREHAM JOHN PDirectorFeb 04Option Exercise25.5436,000919,44049,000Feb 06 08:05 PM
ROBERTS CHRISTOPHER GDirectorFeb 04Option Exercise19.4079,5001,541,955183,930Feb 06 08:04 PM
SULPIZIO RICHARDDirectorFeb 04Option Exercise18.0172,0001,296,612108,387Feb 06 04:51 PM
WAREHAM JOHN PDirectorFeb 04Sale63.4936,0002,285,60413,000Feb 06 08:05 PM
SULPIZIO RICHARDDirectorFeb 04Sale63.1572,0004,546,58436,387Feb 06 04:51 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Feb 03Option Exercise19.255,833112,28564,453Feb 05 08:13 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise25.545,500140,47075,591Feb 05 06:41 PM
Sandercock BrettChief Financial OfficerFeb 03Sale62.8218,6701,172,85160,913Feb 05 08:15 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Feb 03Sale62.356,333394,86358,620Feb 05 08:13 PM
FARRELL PETER CChairman of the BoardFeb 02Option Exercise15.5236,000558,720203,864Feb 04 08:36 PM
FARRELL PETER CChairman of the BoardFeb 02Sale61.9736,0002,230,774167,864Feb 04 08:36 PM
PACE GARY WDirectorJan 26Option Exercise16.5048,000791,904141,158Jan 28 08:24 PM
TAYLOR RONALD RDirectorJan 26Option Exercise15.5236,000558,72071,471Jan 28 08:25 PM
PACE GARY WDirectorJan 26Sale66.7748,0003,204,81693,158Jan 28 08:24 PM
TAYLOR RONALD RDirectorJan 26Sale66.9836,0002,411,31635,471Jan 28 08:25 PM
PENDARVIS DAVIDChief Administrative OfficerJan 05Option Exercise25.545,500140,47075,591Jan 06 02:29 PM
PENDARVIS DAVIDChief Administrative OfficerJan 05Sale57.095,500313,98770,091Jan 06 02:29 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 02Option Exercise18.677,500140,02566,124Jan 06 01:52 PM
FARRELL PETER CChairman of the BoardJan 02Option Exercise15.5236,000558,720203,864Jan 06 12:41 PM
FARRELL PETER CChairman of the BoardJan 02Sale56.9936,0002,051,640167,864Jan 06 12:41 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 02Sale56.998,000455,92558,624Jan 06 01:52 PM
FARRELL PETER CChairman of the BoardDec 01Option Exercise15.5236,000558,720292,375Dec 03 09:09 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 01Option Exercise18.677,500140,02566,624Dec 03 09:11 PM
FARRELL PETER CChairman of the BoardDec 01Sale53.2836,0001,918,188256,375Dec 03 09:09 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 01Sale52.938,000423,44059,124Dec 03 09:11 PM
Sandercock BrettChief Financial OfficerNov 25Sale51.1515,000767,25079,583Dec 01 09:08 PM
FARRELL PETER CChairman of the BoardNov 18Option Exercise15.5236,000558,720292,375Nov 20 09:24 PM
FARRELL PETER CChairman of the BoardNov 18Sale52.3936,0001,886,148256,375Nov 20 09:24 PM
Hollingshead JamesPresident, AmericasNov 11Option Exercise51.1522,9031,171,48862,639Nov 13 08:56 PM
PENDARVIS DAVIDChief Administrative OfficerNov 11Option Exercise33.702,96799,98878,417Nov 13 06:38 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise15.523,55755,20579,007Nov 05 08:54 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 03Option Exercise17.627,500132,15049,797Nov 05 09:02 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale52.003,557184,96475,450Nov 05 08:54 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 03Sale51.848,000414,75544,297Nov 05 09:02 PM
FARRELL PETER CChairman of the BoardOct 29Option Exercise12.47119,2041,486,235400,468Oct 31 07:46 PM
FARRELL PETER CChairman of the BoardOct 29Sale51.84119,2046,179,416281,264Oct 31 07:46 PM
Farrell Michael J.Chief Executive OfficerOct 15Option Exercise21.683,20069,360147,047Oct 17 08:42 PM
Farrell Michael J.Chief Executive OfficerOct 15Sale46.613,200149,158143,847Oct 17 08:42 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise15.525,00077,60080,206Oct 06 08:27 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale49.845,000249,20075,206Oct 06 08:27 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Oct 01Option Exercise15.527,500116,40046,630Oct 03 08:04 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Oct 01Sale49.118,000392,88038,130Oct 03 08:04 PM
Farrell Michael J.Chief Executive OfficerSep 15Option Exercise21.683,20069,360147,047Sep 17 06:24 PM
Farrell Michael J.Chief Executive OfficerSep 15Sale52.413,200167,712143,847Sep 17 06:24 PM
Sandercock BrettChief Financial OfficerSep 05Sale52.9910,000529,87060,913Sep 09 02:10 PM
PENDARVIS DAVIDChief Administrative OfficerSep 03Option Exercise15.525,00077,60080,206Sep 05 07:07 PM
Sandercock BrettChief Financial OfficerSep 03Sale53.2310,000532,26070,913Sep 05 07:08 PM
PENDARVIS DAVIDChief Administrative OfficerSep 03Sale53.235,000266,15075,206Sep 05 07:07 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Sep 02Option Exercise15.527,500116,40046,630Sep 04 05:56 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Sep 02Sale53.008,000423,97838,630Sep 04 05:56 PM
Reiser AnnePresident - ResMed EuropeAug 29Option Exercise17.303,00051,90069,524Sep 03 08:57 PM
Reiser AnnePresident - ResMed EuropeAug 22Sale53.373,000160,11666,524Sep 03 08:57 PM
Farrell Michael J.Chief Executive OfficerAug 15Option Exercise21.683,20069,360109,855Aug 19 07:31 PM
Farrell Michael J.Chief Executive OfficerAug 15Sale51.363,200164,365106,655Aug 19 07:31 PM
PENDARVIS DAVIDChief Administrative OfficerAug 04Option Exercise15.525,00077,60074,207Aug 06 08:02 PM
PENDARVIS DAVIDChief Administrative OfficerAug 04Sale49.125,000245,61769,207Aug 06 08:02 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Aug 01Option Exercise15.527,500116,400105,271Aug 05 05:52 PM
FARRELL PETER CDirectorAug 01Option Exercise12.4725,000311,700329,990Aug 05 07:59 PM
FARRELL PETER CDirectorAug 01Sale49.0425,0001,226,098279,990Aug 05 07:59 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Aug 01Sale48.958,000391,59097,271Aug 05 05:52 PM
Farrell Michael J.Chief Executive OfficerJul 15Option Exercise21.683,20069,360109,855Jul 16 07:36 PM
Farrell Michael J.Chief Executive OfficerJul 15Sale49.223,200157,504106,655Jul 16 07:36 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Option Exercise15.525,00077,60074,207Jul 07 04:44 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Sale50.045,000250,20069,207Jul 07 04:44 PM
Farrell Michael J.Chief Executive OfficerJun 16Option Exercise21.683,20069,360109,855Jun 18 08:07 PM
Farrell Michael J.Chief Executive OfficerJun 16Sale53.203,200170,224106,655Jun 18 08:07 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Option Exercise15.525,00077,60074,207Jun 05 08:58 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Sale49.765,000248,80069,207Jun 05 08:58 PM
FARRELL PETER CDirectorJun 02Option Exercise12.4725,000311,700329,990Jun 04 08:02 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jun 02Option Exercise15.527,500116,400106,271Jun 04 08:04 PM
FARRELL PETER CDirectorJun 02Sale49.5725,0001,239,250304,990Jun 04 08:02 PM